Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Income from Continuing Operations (2016 - 2025)

Phibro Animal Health has reported Income from Continuing Operations over the past 14 years, most recently at 27459000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 27459000.0 for Q4 2025, up 762.14% from a year ago — trailing twelve months through Dec 2025 was 92090000.0 (up 1157.72% YoY), and the annual figure for FY2025 was 48264000.0, up 603.85%.
  • Income from Continuing Operations for Q4 2025 was 27459000.0 at Phibro Animal Health, up from 26527000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for PAHC hit a ceiling of 27459000.0 in Q4 2025 and a floor of 11243000.0 in Q2 2024.
  • Median Income from Continuing Operations over the past 5 years was 7092500.0 (2022), compared with a mean of 8628750.0.
  • Biggest five-year swings in Income from Continuing Operations: crashed 307.86% in 2023 and later surged 762.14% in 2025.
  • Phibro Animal Health's Income from Continuing Operations stood at 17465000.0 in 2021, then plummeted by 58.72% to 7210000.0 in 2022, then tumbled by 82.33% to 1274000.0 in 2023, then surged by 150.0% to 3185000.0 in 2024, then skyrocketed by 762.14% to 27459000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 27459000.0 (Q4 2025), 26527000.0 (Q3 2025), and 17224000.0 (Q2 2025) per Business Quant data.